BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/23/2022 9:24:32 AM | Browse: 330 | Download: 687
Publication Name World Journal of Clinical Oncology
Manuscript ID 73082
Country United States
Received
2021-11-09 00:50
Peer-Review Started
2021-11-09 00:51
To Make the First Decision
Return for Revision
2021-12-27 03:09
Revised
2022-01-09 00:20
Second Decision
2022-01-24 03:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-01-25 03:17
Articles in Press
2022-01-25 03:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-02-16 13:46
Publish the Manuscript Online
2022-02-23 09:24
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Artificial intelligence and cholangiocarcinoma: Updates and prospects
Manuscript Source Unsolicited Manuscript
All Author List Hossein Haghbin and Muhammad Aziz
ORCID
Author(s) ORCID Number
Hossein Haghbin http://orcid.org/0000-0001-8947-287X
Muhammad Aziz http://orcid.org/0000-0001-5620-8597
Funding Agency and Grant Number
Corresponding Author Hossein Haghbin, MD, Doctor, Department of Gastroenterology, Ascension Providence Southfield, 16001 W Nine Mile Road, Southfield, MI 48075, United States. hoshaq@yahoo.com
Key Words Artificial intelligence; Machine learning; Cholangiocarcinoma; Diagnosis; Treatment; Prognosis
Core Tip The wide array of modalities available to treat cholangiocarcinoma (CCA) in addition to the diversity of the tumor urges us to use individualized therapy. To establish the proper approach to diagnose, treat, and prognose CCA, analysis of available data is the key to achieve the individualized care. Artificial intelligence can be a potential modality for achieving this goal.
Publish Date 2022-02-23 09:24
Citation Haghbin H, Aziz M. Artificial intelligence and cholangiocarcinoma: Updates and prospects. World J Clin Oncol 2022; 13(2): 125-134
URL https://www.wjgnet.com/2218-4333/full/v13/i2/125.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i2.125
Full Article (PDF) WJCO-13-125.pdf
Full Article (Word) WJCO-13-125.docx
Manuscript File 73082_Auto_Edited.docx
Answering Reviewers 73082-Answering reviewers.pdf
Audio Core Tip 73082-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 73082-Conflict-of-interest statement.pdf
Copyright License Agreement 73082-Copyright license agreement.pdf
Peer-review Report 73082-Peer-review(s).pdf
Scientific Misconduct Check 73082-CrossCheck.jpg
Scientific Misconduct Check 73082-Bing-Gong ZM-2.jpg
Scientific Editor Work List 73082-Scientific editor work list.pdf